Skip to content

Strategic Directions 2020

Helping to achieve HIV epidemic control in California by 2025

Mission:


To support principal investigators in California to develop, evaluate, and disseminate innovative research for eliminating new HIV infections; optimizing treatment uptake and outcomes for all persons living with HIV infection; and addressing the comorbidities and social determinants that threaten the health and well-being of persons at risk for or living with HIV infection.

Strategic Directions:

  • Fosters the meaningful engagement of stakeholders– including persons living with or at risk for HIV infection, communities, policy-makers, academics, and services providers – in the design, conduct, interpretation, and dissemination of research findings.
  • Supports the development and sustainability of research and evaluation capacity among key partners in the public health response to HIV in California, including public health departments, community-based organizations, and advocates.
  • Invests in high-risk, high-reward, high-rigor research that has the potential to substantially and rapidly advance HIV epidemic control.
  • Addresses unmet needs for HIV research by prioritizing areas that are not addressed by other funders.
  • Supports implementation science designed to generate actionable knowledge that, when taken to scale, offers effective and cost-effective approaches for stemming new infections and averting HIV-associated morbidity and mortality.
  • Encourages a rapid-cycle iteration approach to developing, implementing, evaluating, and advancing strategies leading to the evidence-based transformation of clinical care systems and public health practices.
  • Welcomes a complexity science approach that appreciates the dynamic, interconnected relationships between biological, personal, social, and structural determinants of HIV infection risk and associated morbidity.
  • Funds research that iIluminates and mitigates social determinants associated both with inequitable access to prevention and treatment services and disparate health outcomes.
  • Adopts a syndemics approach to health and disease that addresses common HIV-co-morbidities (e.g., Hepatitis C, other STIs, Substance Use Disorders).